Health Trials

ANCA-Associated Glomerulonephritis (AAGN)

1

Review clinical trials related to ANCA-Associated Glomerulonephritis (AAGN). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Obinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis

This study is an open-label, single-arm, exploratory study designed to evaluate the efficacy and safety of Obinutuzumab beta combined with a rapid-tapering glucocorticoid regimen in patients with new-onset ANCA-associated glomerulonephritis (AAGN).

Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Chinese PLA General HospitalUpdated: Aug 4, 2026
Eligibility criteria

New diagnosis of ANCA-associated vasculitis (Granulomatosis with polyangiitis [G... [+3]

Prior treatment with targeted B-cell therapies (e.g., Rituximab) or standard cyc... [+6]

Read more